search
Back to results

Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants

Primary Purpose

Hydrocephalus

Status
Active
Phase
Phase 3
Locations
Uganda
Study Type
Interventional
Intervention
Chhabra Shunt Placement
ETV/CPC
Sponsored by
Boston Children's Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hydrocephalus

Eligibility Criteria

1 Day - 180 Days (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Infants less than 180 days (six months) old
  • Symptomatic hydrocephalus
  • Post-infectious Hydrocephalus based on clinical and CT parameters2
  • Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo

Exclusion Criteria:

  • Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation
  • Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement
  • Any patient with absence of any visible cortical mantle on the CT
  • Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC

Sites / Locations

  • CURE Children's Hospital Uganda

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

Chhabra Shunt Placement

ETV/CPC

Arm Description

The shunting arm will comprise a standard frontal approach ventriculoperitoneal shunt using a silastic Chhabra system.

The Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) arm will comprise a standard frontal approach with flexible endoscopy.

Outcomes

Primary Outcome Measures

Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores
Neurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment).

Secondary Outcome Measures

Brain Volume
Volume unit of measure is cubic millimeters. Volume is measured using CT scans.
CSF Volume
Volume unit of measure is cubic millimeters. Volume is measured using CT scans.
Vineland Adaptive Behavior Scales
The primary purpose of the VABS is to assess the social abilities of school age children.

Full Information

First Posted
July 29, 2013
Last Updated
August 14, 2023
Sponsor
Boston Children's Hospital
Collaborators
Penn State University, The Hospital for Sick Children, CURE Children's Hospital, Uganda
search

1. Study Identification

Unique Protocol Identification Number
NCT01936272
Brief Title
Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants
Official Title
Neurocognitive Outcomes and Changes in Brain and Cerebral Spinal Fluid (CSF) Volume After Treatment of Post-Infectious Hydrocephalus (PIH) in Ugandan Infants by Shunting Versus ETV/CPC
Study Type
Interventional

2. Study Status

Record Verification Date
August 2023
Overall Recruitment Status
Active, not recruiting
Study Start Date
May 27, 2013 (Actual)
Primary Completion Date
December 2025 (Anticipated)
Study Completion Date
December 2025 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Boston Children's Hospital
Collaborators
Penn State University, The Hospital for Sick Children, CURE Children's Hospital, Uganda

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Two treatment options exist for infant patients with hydrocephalus. Most patients are treated with a surgical procedure in which a shunt is inserted into the brain and abdomen. In recent years, however, another treatment has developed called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC).This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This study will evaluate patients in more detail to measure brain growth and development.
Detailed Description
World over, infants with hydrocephalus are mainly treated using a shunt, which is a device made of soft plastic tubing that moves extra fluid from the brain to the abdomen. Surgery is required to insert a shunt into the brain and the abdomen. In recent years, we have developed another treatment called Endoscopic Third Ventriculostomy (ETV) with Choroid Plexus Cauterization (ETV/CPC). This research study is being done to measure the results of these procedures in children less than six months of age who have hydrocephalus as the result of a brain infection, called post-infectious hydrocephalus, or PIH. This is the most common cause of hydrocephalus in Ugandan babies. This study will evaluate patients in more detail to measure brain growth and development. Children in the study will have special testing to measure developmental progress as well as special imaging to evaluate the progress of their brain growth.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hydrocephalus

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Single Group Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
100 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Chhabra Shunt Placement
Arm Type
Active Comparator
Arm Description
The shunting arm will comprise a standard frontal approach ventriculoperitoneal shunt using a silastic Chhabra system.
Arm Title
ETV/CPC
Arm Type
Active Comparator
Arm Description
The Endoscopic Third Ventriculostomy/Choroid Plexus Cauterization (ETV/CPC) arm will comprise a standard frontal approach with flexible endoscopy.
Intervention Type
Device
Intervention Name(s)
Chhabra Shunt Placement
Intervention Type
Procedure
Intervention Name(s)
ETV/CPC
Primary Outcome Measure Information:
Title
Change of Age-normed Bayley Scales of Infant Development (BSID)-III scores
Description
Neurocognition will be measured using the BSID-III Cognitive Scale. Change will be assessed at 24 months post treatment from baseline score (12 months post treatment).
Time Frame
12 months and 24 months post treatment
Secondary Outcome Measure Information:
Title
Brain Volume
Description
Volume unit of measure is cubic millimeters. Volume is measured using CT scans.
Time Frame
12 months, 24 months, 5 years, and 7-10 years post treatment
Title
CSF Volume
Description
Volume unit of measure is cubic millimeters. Volume is measured using CT scans.
Time Frame
12 months, 24 months, 5 years, and 7-10 years post treatment
Title
Vineland Adaptive Behavior Scales
Description
The primary purpose of the VABS is to assess the social abilities of school age children.
Time Frame
5 years and 7-10 years post treatment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
1 Day
Maximum Age & Unit of Time
180 Days
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Infants less than 180 days (six months) old Symptomatic hydrocephalus Post-infectious Hydrocephalus based on clinical and CT parameters2 Must be from the following Ugandan districts: Bugiri, Busia, Iganga, Jinja, Kampala, Kamuli, Kapchorwa, Katakwi, Kumi, Mayuge, Mbale, Mukono, Pallisa, Sironko, Soroti, and Tororo Exclusion Criteria: Any patient with a scalp erosion or infection that would exclude the patient from shunt implantation Any patient with ventricular loculations that would normally indicate the use of ventriculoscopy as an adjunct to shunt placement Any patient with absence of any visible cortical mantle on the CT Patients must be appropriate candidates for either surgical procedure - shunt placement alone or ETV/CPC
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Benjamin C Warf, MD
Organizational Affiliation
Boston Children's Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
CURE Children's Hospital Uganda
City
Mbale
Country
Uganda

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
IPD will not be shared with researchers outside of the study team.
Citations:
PubMed Identifier
34911199
Citation
Harper JR, Cherukuri V, O'Reilly T, Yu M, Mbabazi-Kabachelor E, Mulando R, Sheth KN, Webb AG, Warf BC, Kulkarni AV, Monga V, Schiff SJ. Assessing the utility of low resolution brain imaging: treatment of infant hydrocephalus. Neuroimage Clin. 2021;32:102896. doi: 10.1016/j.nicl.2021.102896. Epub 2021 Nov 23.
Results Reference
derived
PubMed Identifier
31086941
Citation
Punchak M, Mbabazi Kabachelor E, Ogwal M, Nalule E, Nalwoga J, Ssenyonga P, Mugamba J, Rattani A, Dewan MC, Kulkarni AV, Schiff SJ, Warf B. The Incidence of Postoperative Seizures Following Treatment of Postinfectious Hydrocephalus in Ugandan Infants: A Post Hoc Comparison of Endoscopic Treatment vs Shunt Placement in a Randomized Controlled Trial. Neurosurgery. 2019 Oct 1;85(4):E714-E721. doi: 10.1093/neuros/nyz122.
Results Reference
derived
PubMed Identifier
29262276
Citation
Kulkarni AV, Schiff SJ, Mbabazi-Kabachelor E, Mugamba J, Ssenyonga P, Donnelly R, Levenbach J, Monga V, Peterson M, MacDonald M, Cherukuri V, Warf BC. Endoscopic Treatment versus Shunting for Infant Hydrocephalus in Uganda. N Engl J Med. 2017 Dec 21;377(25):2456-2464. doi: 10.1056/NEJMoa1707568.
Results Reference
derived

Learn more about this trial

Randomized Controlled Trial of Shunt vs ETV/CPC for PIH in Ugandan Infants

We'll reach out to this number within 24 hrs